High-Pressure Injection Injuries of the Hand - Report of Two Cases

Utrobičić, Ivan; Pogorelić, Zenon; Družijanić, Nikica

doi:10.1080/00015458.2011.11680704

Cited by 5 publications

(12 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Ob ra że nia ty pu HPII do ty czą przede wszyst kim mło dych mę żczyzn (wy pa dek w trak cie pra cy), umiejsca wia ją się na rę ce nie do mi nu ją cej i do ty czą opusz ki pal ca II [2,3,4,5,6,9,11,13]. Dru gim pod wzglę dem czę sto ści jest kciuk i pa lec środ ko wy.…”

Section: Discussionunclassified

“…High-pressure injection injuries are mostly seen in young men (accidents at work) and involve the pulp of the 2 nd finger in the non-dominant hand [2,3,4,5,6,9,11,13], with the thumb and the middle finger as the second most common locations.…”

Section: Discussionmentioning

confidence: 99%

“…Wy so ko ci śnie nio we na strzyk nię cia tka nek (High -Pres su re In jec tion In ju ry -HPII) to rzad ko wy stę pują ce, cię żkie ob ra że nia rę ki, obar czo ne wy so kim odset kiem po wi kłań, am pu ta cji ob wo do wych czę ści pal ców i utrwa lo nym upo śle dze niem funk cji rę ki [1,2,3,4,5].…”

Section: Wstępunclassified

“…Przed ura zem cho ry dys po no wał pra wie peł nym za kre sem funk cji rę ki. Ki kut kciu ka po sia dał pe łen za -BACKGROUND High-pressure injection injury (HPII) is a rare severe hand trauma associated with high rates of complications and amputations of the peripheral parts of the fingers and permanent hand dysfunction [1,2,3,4,5].…”

Section: Ana LI Za Przy Pad Kumentioning

confidence: 99%

“…ma ła ra na wlo to wa, nie wiel ki obrzęk i ból to wa rzy szą cy ura zo wi), sta no wią po wa żny problem kli nicz ny, któ ry bez szyb kiej in ter wen cji chirur gicz nej i kom plek so we go le cze nia, mo że do prowa dzić do znacz ne go upo śle dze nia zdol no ści chwytnej rę ki. [1,2,5,6,9,11] Ro ko wa nia pa cjen ta są uza le żnio ne od czte rech głów nych czyn ni ków: a) cha rak te ry sty ka che micz na sub stan cji wstrzyk niętej (typ, tok sycz ność, ob ję tość i lep kość)wstrzyk nię cie far by bądź roz pusz czal ni ków chemicz nych wią że się z du żo gor szym ro ko wa niem (od se tek am pu ta cji się ga 80%), niż w przy pad ku wstrzyk nię cia np. wo dy lub ga zu (w tych przypad kach mo żna roz wa żyć le cze nie za cho wawcze).…”

Section: Pod Su Mo Wa Nieunclassified

See 4 more Smart Citations

High Pressure Injection Injury of the Thumb. Case Study

Zamkowski¹,

Ropel²,

Baczkowski³

et al. 2015

Ortop Traumatol Rehabil

View full text Add to dashboard Cite

High-pressure injection injury (HPII) is a rare severe hand trauma associated with high rates of complications and amputations of the peripheral parts of the fingers and permanent hand dysfunction. Early detection and treatment are crucial as any delay may result in a considerable functional deficit of the affected limb or amputation. The rate of amputation following HPII is 48%. This case report aims mainly to present the problem of HPII and general standards of management of such injuries. The routine use of supportive treatment in hyperbaric chambers, in the absence of contraindications, is also encouraged.

show abstract

Section: Discussionunclassified

Section: Discussionmentioning

confidence: 99%

Section: Wstępunclassified

Section: Ana LI Za Przy Pad Kumentioning

confidence: 99%

Section: Pod Su Mo Wa Nieunclassified

See 3 more Smart Citations

High Pressure Injection Injury of the Thumb. Case Study

Zamkowski¹,

Ropel²,

Baczkowski³

et al. 2015

Ortop Traumatol Rehabil

View full text Add to dashboard Cite

show abstract

Veterinary Medicinal Products

Woodward¹

2018

Regulatory Toxicology in the European Union

View full text Add to dashboard Cite

In the European Union, veterinary medicinal products are assessed for their safety prior to being issued with a marketing authorisation, and in this context, safety includes toxicological safety. The results of toxicity testing are used to assess the safety of a product for the animal patient, for the consumer of food derived from treated animals and for the users of animal medicines or to those indirectly exposed, including people stroking pets given topical treatments. The requirements for testing, and advice on the methods and approaches to testing, are set out in European Union guidance and other documents. This chapter discusses the major requirements and approaches for safety testing, paying particular regard to consumer and user safety.

show abstract

The Assessment of User Safety

Woodward¹

2012

Toxicological Effects of Veterinary Medicinal Products in Humans

View full text Add to dashboard Cite

Veterinary medicinal products are used by a variety of people including veterinary professionals, farmers and members of the pet-owning public. These users may become exposed to veterinary products and their constituents when animals are treated and has a result, they may experience adverse reactions. Hazards may arise from pharmacological or toxicological properties, or from physical characteristics such as the flammability of solvents used in the formulation. Prior to authorisation, veterinary medicinal products are evaluated for their potential to cause harm to users based on the biological and physical properties of the formulation. Hazards and associated risks are identified and the relevant information and protective measures to be adopted conveyed to users through labelling and descriptions in product literature. Restrictions on use or product availability may also be used to mitigate risks.

show abstract

High-Pressure Injection Injuries of the Hand - Report of Two Cases

Cited by 5 publications

References 9 publications

High Pressure Injection Injury of the Thumb. Case Study

High Pressure Injection Injury of the Thumb. Case Study

Veterinary Medicinal Products

The Assessment of User Safety

Contact Info

Product

Resources

About